Article
The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.
Breast cancer research and treatment - 1 Apr 2015
Villarreal-Garza C, Weitzel J N, Llacuachaqui M, Sifuentes E, Magallanes-Hoyos M C, Gallardo L, Alvarez-Gómez R M, Herzog J, Castillo D, Royer R, Akbari Mohammad, Lara-Medina F, Herrera L A, Mohar A, Narod S A
Abstract excerpt
Various guidelines recommend that women with triple-negative breast cancer should be tested for BRCA1 mutations, but the prevalence of mutations may vary with ethnic group and with geographic region, and the optimal cutoff age for testing has not been established. We estimated the frequencies of BRCA1 and BRCA2 (BRCA) mutations among 190 women with triple-negative breast cancer, unselected for family history,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.